Short-term effects of intravitreal bevacizumab in contrast sensitivity of patients with diabetic macular edema and optimizing glycemic control

•Anti-VEGF therapy associated with optimizing glicemic control leads to superior approach to the treatment of diabetic macular edema.•The contrast sensitivity could play an important role in the visual evaluation of diabetic macular edema.•Glycemic control with hemoglobin A1c levels shown to be effe...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes research and clinical practice 2019-03, Vol.149, p.170-178
Hauptverfasser:	Motta, Augusto A.L., Bonanomi, Maria Teresa B.C., Ferraz, Daniel A., Preti, Rony C., Sophie, Raafay, Abalem, Maria F., Queiroz, Marcia S., Pimentel, Sérgio L.G., Takahashi, Walter Y., Damico, Francisco M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bevacizumab Contrast sensitivity Diabetic macular edema Glycemic control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!